-
Researchers target metastasis in fight against cancer
worldpharmanews
March 29, 2019
An experimental combination drug therapy attacking the DNA integrity of cancer cells is showing promise for a possible new cancer therapy in the future.
-
GT Biopharma Restructures Management Team
contractpharma
March 27, 2019
Cataldo named chief executive officer, Weldon appointed as chief financial officer.
-
Pivotal phase III trial launched in recurrent ovarian cancer
europeanpharmaceuticalreview
March 26, 2019
INNOVATE-3 will test the efficacy of Tumor Treating Fields combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer…
-
FDA Warns Homeopathic Company About Illegal Product Claims
drugs
March 20, 2019
Nutra Pharma Corp. has been warned about illegal marketing of unapproved homeopathic products with claims that they can treat addiction and chronic pain from serious conditions such as cancer, diabetes, shingles, and fibromyalgia, the U.S. Food and Drug A
-
When a cell's 'fingerprint' can be a weapon against cancer
worldpharmanews
March 14, 2019
The study published in the scientific journal PLoS Computational Biology shows the types of tumors in which these genes are most active and identifies drugs with the potential to selectively eliminate cells that carry that label.
-
Cellectis to Build Mfg. Facility in North Carolina
contractpharma
March 13, 2019
With help from CMO partners, advances further towards commercialization of UCART portfolio
-
A third cancer-causing impurity detected in U.S. supply of blood pressure drug
fiercepharma
March 08, 2019
Just when it appeared the FDA was close to purging the U.S. drug supply of potential cancer-causing impurities in sartan blood pressure drugs, another massive recall has been launched. This time it is for an entirely new contaminant.
-
Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For the Treatment of HPV-Related Cervical Pre-cancer
en-cphi.cn
March 07, 2019
The second Phase 3 study initiation announcement made during the International HPV Awareness Day
-
‘Smart drug’ shows promise for metastatic triple-negative breast cancer
europeanpharmaceuticalreview
February 22, 2019
A study has shown that a ‘smart drug’ that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer…
-
Keytruda gets okay from FDA for adjuvant melanoma
pharmaphorum
February 21, 2019
The US FDA has approved Merck & Co’s Keytruda as an adjuvant treatment for patients with melanoma who have had surgery but still show some evidence of cancer in their lymph nodes.